已收盤 09-19 16:00:00 美东时间
+3.710
+5.76%
Deep-pocketed investors have adopted a bullish approach towards Viking Therapeu...
09-18 01:46
Morgan Stanley analyst Michael Ulz reiterates Viking Therapeutics (NASDAQ:VKTX) with a Overweight and maintains $105 price target.
09-12 20:11
美国小型制药商Viking Therapeutics (VKTX.US)盘前续涨2.91%,该股昨日大幅上涨超11%。摩根大通指出,公司旗下减肥药物VK273...
09-12 17:20
小摩予Viking Therapeutics“增持”评级,目标价为80美元,并将该股列入积极观察名单。
09-12 11:21
JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics with an Overweight rating and a December 2025 price target of $80.
09-12 01:55
Investors with a lot of money to spend have taken a bullish stance on Viking Th...
09-12 00:30
U.S. stock index futures on Wednesday pointed to a mixed open, as market participants digested the latest consumer inflation report. Here are some stocks to watch on Wednesday: U.S.-listed shares of ...
09-11 21:14
Shares of Viking Therapeutics (NASDAQ:VKTX) traded higher in the premarket on Wednesday as J.P. Morgan launched its coverage with a buy-equivalent rating of Overweight, citing an upcoming early-stage ...
09-11 20:40
根据晨星公司和Pitchbook的一份新报告,到2029年,可能会有多达16种新的GLP-1类减肥药物上市,最终将占据到2031年潜在的2000亿美元市场的近三分之一。
09-11 10:44